Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
S Ronnebaum, M Bron, D Patel, D Menno… - Journal of Clinical …, 2021 - jcsm.aasm.org
Study Objectives: Excessive daytime sleepiness associated with obstructive sleep apnea
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
S Ronnebaum, M Bron, D Patel… - Journal of clinical …, 2021 - pubmed.ncbi.nlm.nih.gov
Study objectives Excessive daytime sleepiness associated with obstructive sleep apnea
affects 9%-22% of continuous positive airway pressure-treated patients. An indirect …
affects 9%-22% of continuous positive airway pressure-treated patients. An indirect …
Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea.
S Ronnebaum, M Bron, D Patel, D Menno… - Journal of Clinical …, 2021 - europepmc.org
Study objectives Excessive daytime sleepiness associated with obstructive sleep apnea
affects 9%-22% of continuous positive airway pressure-treated patients. An indirect …
affects 9%-22% of continuous positive airway pressure-treated patients. An indirect …
[HTML][HTML] Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea
S Ronnebaum, M Bron, D Patel, D Menno… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
Study Objectives: Excessive daytime sleepiness associated with obstructive sleep apnea
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …
affects 9%–22% of continuous positive airway pressure–treated patients. An indirect …